Antiphospholipid syndrome historical perspective: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Antiphospholipid syndrome}} | {{Antiphospholipid syndrome}} | ||
{{CMG}}{{AE}}{{FT}} | {{CMG}}; {{AE}}{{FT}} | ||
==Overview== | ==Overview== | ||
In the early 1980s, the term antiphospholipid syndrome was coined to describe a unique form of autoantibody-induced [[thrombophilia]]. In 1999, Sapporo classification criteria for APS was published. In 2006, the preliminary Sapporo criteria was revised with the inclusion of anti- | In the early 1980s, the term antiphospholipid syndrome was coined to describe a unique form of autoantibody-induced [[thrombophilia]]. In 1999, Sapporo classification criteria for APS was published. In 2006, the preliminary Sapporo criteria was revised with the inclusion of anti-β2 glycoprotein I antibodies (GPI) [[antibodies]] in the [[diagnostic criteria]]. | ||
==Historical Perspective== | ==Historical Perspective== | ||
The historical perspective of antiphospholipid syndrome(APS) is as follows:<ref name="pmid16420554">{{cite journal| author=Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R et al.| title=International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). | journal=J Thromb Haemost | year= 2006 | volume= 4 | issue= 2 | pages= 295-306 | pmid=16420554 | doi=10.1111/j.1538-7836.2006.01753.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16420554 }} </ref><ref name="pmid20149305">{{cite journal| author=Solano C, Lamuño M, Vargas A, Amezcua-Guerra LM| title=Comparison of the 1999 Sapporo and 2006 revised criteria for the classification of the antiphospholipid syndrome. | journal=Clin Exp Rheumatol | year= 2009 | volume= 27 | issue= 6 | pages= 914-9 | pmid=20149305 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20149305 }} </ref><ref name="pmid17337473">{{cite journal| author=Kaul M, Erkan D, Sammaritano L, Lockshin MD| title=Assessment of the 2006 revised antiphospholipid syndrome classification criteria. | journal=Ann Rheum Dis | year= 2007 | volume= 66 | issue= 7 | pages= 927-30 | pmid=17337473 | doi=10.1136/ard.2006.067314 | pmc=2497429 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17337473 }} </ref> | The historical perspective of antiphospholipid syndrome (APS) is as follows:<ref name="pmid16420554">{{cite journal| author=Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R et al.| title=International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). | journal=J Thromb Haemost | year= 2006 | volume= 4 | issue= 2 | pages= 295-306 | pmid=16420554 | doi=10.1111/j.1538-7836.2006.01753.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16420554 }} </ref><ref name="pmid20149305">{{cite journal| author=Solano C, Lamuño M, Vargas A, Amezcua-Guerra LM| title=Comparison of the 1999 Sapporo and 2006 revised criteria for the classification of the antiphospholipid syndrome. | journal=Clin Exp Rheumatol | year= 2009 | volume= 27 | issue= 6 | pages= 914-9 | pmid=20149305 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20149305 }} </ref><ref name="pmid17337473">{{cite journal| author=Kaul M, Erkan D, Sammaritano L, Lockshin MD| title=Assessment of the 2006 revised antiphospholipid syndrome classification criteria. | journal=Ann Rheum Dis | year= 2007 | volume= 66 | issue= 7 | pages= 927-30 | pmid=17337473 | doi=10.1136/ard.2006.067314 | pmc=2497429 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17337473 }} </ref> | ||
* In the early 1980s, the term antiphospholipid syndrome was coined to describe a unique form of [[autoantibody]]-induced [[thrombophilia]], whose hallmarks are complications in [[pregnancy]] complications and recurrent [[thrombosis]]. | * In the early 1980s, the term antiphospholipid syndrome was coined to describe a unique form of [[autoantibody]]-induced [[thrombophilia]], whose hallmarks are complications in [[pregnancy]] complications and recurrent [[thrombosis]]. | ||
* In 1999, Sapporo classification criteria for APS were published in an international consensus statement in Sydney, Australia. | * In 1999, Sapporo classification criteria for APS were published in an international consensus statement in Sydney, Australia. | ||
*In 2006, the preliminary Sapporo criteria was revised with the inclusion of anti- | *In 2006, the preliminary Sapporo criteria was revised with the inclusion of anti-β2 glycoprotein I antibodies in the [[diagnostic criteria]]. | ||
==References== | ==References== | ||
Revision as of 13:52, 24 April 2018
|
Antiphospholipid syndrome Microchapters |
|
Differentiating Antiphospholipid syndrome from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Antiphospholipid syndrome historical perspective On the Web |
|
American Roentgen Ray Society Images of Antiphospholipid syndrome historical perspective |
|
Antiphospholipid syndrome historical perspective in the news |
|
Risk calculators and risk factors for Antiphospholipid syndrome historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Feham Tariq, MD [2]
Overview
In the early 1980s, the term antiphospholipid syndrome was coined to describe a unique form of autoantibody-induced thrombophilia. In 1999, Sapporo classification criteria for APS was published. In 2006, the preliminary Sapporo criteria was revised with the inclusion of anti-β2 glycoprotein I antibodies (GPI) antibodies in the diagnostic criteria.
Historical Perspective
The historical perspective of antiphospholipid syndrome (APS) is as follows:[1][2][3]
- In the early 1980s, the term antiphospholipid syndrome was coined to describe a unique form of autoantibody-induced thrombophilia, whose hallmarks are complications in pregnancy complications and recurrent thrombosis.
- In 1999, Sapporo classification criteria for APS were published in an international consensus statement in Sydney, Australia.
- In 2006, the preliminary Sapporo criteria was revised with the inclusion of anti-β2 glycoprotein I antibodies in the diagnostic criteria.
References
- ↑ Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R; et al. (2006). "International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)". J Thromb Haemost. 4 (2): 295–306. doi:10.1111/j.1538-7836.2006.01753.x. PMID 16420554.
- ↑ Solano C, Lamuño M, Vargas A, Amezcua-Guerra LM (2009). "Comparison of the 1999 Sapporo and 2006 revised criteria for the classification of the antiphospholipid syndrome". Clin Exp Rheumatol. 27 (6): 914–9. PMID 20149305.
- ↑ Kaul M, Erkan D, Sammaritano L, Lockshin MD (2007). "Assessment of the 2006 revised antiphospholipid syndrome classification criteria". Ann Rheum Dis. 66 (7): 927–30. doi:10.1136/ard.2006.067314. PMC 2497429. PMID 17337473.